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Total knee replacements (TKRs) are known to be very successful procedures that are often associated with lengthy and painful recoveries. Great strides have been made in the last several years in minimizing patient discomfort and enhancing their recovery. Less invasive surgical approaches, more selective soft tissue balancing, improved patient education, and perhaps instrument and implant design have all contributed to an overall easier recovery for a patient undergoing TKR. However, improvements in pain control deserve the greatest credit for the more rapid recoveries that are now being seen [@bib1].

Options for postoperative pain control include patient administered narcotics, epidural anesthetics, and spinal anesthetics with adjuncts such as long-acting morphine and peripheral nerve blocks (with and without catheters). These concepts are widely used, but there are reports of multiple side effects secondary to parenteral opioids and problems associated with motor blockade after nerve blocks, which can lead to delays in rehabilitation [@bib2], [@bib3], [@bib4].

Because of dissatisfaction with the aforementioned modalities, the concept of a multimodal pain protocol, along with preemptive analgesia, has gained wide acceptance as a means of controlling pain after TKR. Most multimodal pain protocols currently include some combination of anti-inflammatories, nonnarcotic medications, and limited narcotic use. Perhaps the most important component of a multimodal pain protocol is the use of local infiltrative analgesia (LIA). This article focuses on the use of a periarticular LIA combination technique.

Office tip {#sec2}
==========

This comprehensive pain protocol after TKR has been very successful in my practice ([Table 1](#tbl1){ref-type="table"}).

Discussion {#sec3}
==========

Modern pain protocols were developed as a result of both surgeon and patient recognition that advances were needed to improve patient recovery after TKR. The concepts of preemptive analgesia and multimodal pain protocols are commonly used. LIA is an important component of a multimodal protocol.

Since Kerr and Kohan [@bib5] published one of the earliest reports of the benefits of an LIA pain protocol in 2008, a growing body of literature has supported this concept, along with a multimodal oral regimen that includes preemptive analgesics, and many studies have reported substantial improvements in patient recoveries with this regimen after TKR [@bib2], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9]. LIA offers several advantages over peripheral blocks, including the fact that they can be administered by the orthopaedic surgeon directly into the locally traumatized tissues, they do not require a particular skill set, and, importantly, they do not cause motor blockade, which enables patients to be more active earlier. The ability to avoid or limit the use of narcotics has many advantages for the patient.

Various "cocktails" have been suggested for the local injections. Most include a long-acting local anesthetic along with epinephrine and other additives such as opioids or ketorolac, corticosteroids, and various antibiotics [@bib10], [@bib11], [@bib12], [@bib13]. Although little scientific data exist to help delineate the most effective combination, a prospective, randomized, double-blinded study to evaluate the efficacy of several ingredients in a periarticular "cocktail"---ropivacaine, epinephrine, ketorolac, and clonidine---that had been used for an LIA was undertaken [@bib14]. The study showed that, overall, patient pain control was highest and functional outcome was enhanced when all 4 of the ingredients were combined. The particular mixture that was evaluated included ropivacaine 0.5% (49.25 mL), epinephrine 0.5 mg (0.5 mL), ketorolac 30 mg (1 mL), clonidine 80 mcg (0.8 mL), and sterile water (48.45 mL) for a total of 100 mL. The hospital pharmacist mixed the ingredients and delivered them in a sterile container each day for the day's cases. The stability and sterility of this mixture at 48 hours was tested by an independent laboratory. In addition to having been shown to be effective in decreasing patient pain and enhancing earlier function, this mixture has the advantage that the ingredients are inexpensive (total estimated cost, \$46) and easily available and, therefore, could be used in most centers.

Although no publications have been identified that demonstrate differences attributable to the method of injection, experience has shown that the technique of injection is also an important aspect of LIA. The goal is to deliver as much of the fluid as possible into the tissues, where it will be most effective. Using smaller needles, such as 22 gauge, is the best choice, and using control syringes (that allow for aspiration before injection and are also more comfortable for the hand) are helpful when injecting in areas of potential danger such as the posterior midline of the knee. Using 2 syringes allows the nurses to draw up the syringe as the surgeon is injecting and keeps the process moving. Multiple, small, slow injections are most effective. Aiming to deliver the injection into the areas that are known to be most sensitive, such as the periosteum, the posterior capsule, and the fat pad, is crucial. One should see an actual elevation of the periosteum off the femur to ensure that that tissue has been injected. One should aim to cover the entire surgical site, but it has been found that the skin incision needs the least amount (usually 10-15 mL).

Currently, an identical combination is used in each patient regardless of age, weight, and diagnosis. No nerve palsies nor any cases of intravascular injection have been identified, nor have any issues with skin healing, even with epinephrine in the mixture.

Although the LIA composition and method of delivery are the most important considerations in a comprehensive pain control (and rehabilitation) protocol, several other aspects are also essential to keep the patient comfortable: a supplemental multimodal pain program, control of nausea and vomiting, and limiting bleeding. Currently, the favored supplemental program consists of a nonsteroidal anti-inflammatory drug, acetaminophen, gabapentin, ketorolac, and a limited amount of short-acting oral narcotics, which work synergistically. Control of nausea and vomiting is accomplished with intravenous hydrocortisone sodium succinate for most patients, with liberal use of ondansetron as needed. The use of tranexamic acid has been extremely effective in limiting blood loss, bruising, and the need for transfusions and has been shown to be cost-effective [@bib15], [@bib16]. There are several protocols for the use of this medication, but currently the regimen favored is 1 g intravenously at the time of incision and an additional 1 g at the time of skin closure for all patients, regardless of weight, unless the patient has a contraindication to the use of an antifibrinolytic.

Summary {#sec4}
=======

The combination of an effective, technically well-delivered LIA, in addition to a multimodal supplemental pain program and the use of tranexamic acid to control bleeding has revolutionized the postoperative recovery after TKR. Patient, nursing, and physical therapist satisfaction is extremely high. For the patient being discharged home (not being transferred to an inpatient rehabilitation center) after TKR, the average in-hospital length of stay has decreased to 1.2 days, with most patients being discharged within 24 hours, and all by 48 hours.

Enhanced pain control and early rehabilitation are desired by patients and surgeons alike. Although there are numerous choices by which to achieve these goals, the above combination has been found to be safe and extremely effective.
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Perioperative and postoperative pain protocols after total knee arthroplasty.

  Medication by time point         Dose                           Route             Frequency                Notes
  -------------------------------- ------------------------------ ----------------- ------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Preoperative                                                                                               
   Celecoxib                       400 mg                         Oral              1 Dose                   If allergic, meloxicam 15 mg may be substituted
  Prep room                                                                                                  
   Aprepitant                      40 mg                          Oral              1 Dose                   For female patients with a history of PONV
   Scopolamine transdermal patch   1 mg                           Transdermal       1 Dose                   For patients with a history of PONV
   Oxycontin                       10 mg                          Oral              1 Dose                   For men 70 y or older
   Oxycontin                       20 mg                          Oral              1 Dose                   For men younger than 70 y
  Intraoperative                                                                                             
   Ropivicaine                     5 mg/mL (49.25 mL)             Intra-articular   1 Dose                   Local infiltrative analgesia; normal saline added to medications to total 100 mL; delivered with 22-gauge needle into periosteum of femur and tibia, as well as posterior capsule and arthrotomy; minimal injection needed in skin incision
   Ketorolac                       30 mg/mL (1 mL)                                                           
   Epinephrine                     1 mg/mL (0.5 mL)                                                          
   Clonidine                       0.1 mg/mL (0.08 mg = 0.8 mL)                                              
  Postoperative                                                                                              
   Ondansetron                     4 mg                           Intravenous       1 Dose every 8 h         As needed for nausea
   Solu-Cortef                     100 mg                         Intravenous       1 Dose every 8 h         For 24 h
   Oxycodone                       5 mg                           Oral              1-2 Tablets every 4 h    As needed
   Acetaminophen                   1000 mg                        Oral              1 Tablet 3 times a day   Maximum 3 g/day
   Celecoxib                       400 mg                         Oral              Once daily               
   Tramadol                        50 mg                          Oral              1 Dose every 6 h         As needed; maximum 300 mg/day
   Neurontin                       300 mg                         Oral              1 Dose every 6 h         As needed
   Ketorolac                       30 mg                          Intravenous       1 Dose                   As needed for breakthrough pain
   Hydromorphone                   0.5 mg                         Intravenous       1 Dose every 6 h         As needed
  Discharge                                                                                                  
   Celecoxib                       400 mg (200 mg)                Oral              Once daily               400 mg for 2 wk postoperatively (reduce dose to 200 mg for an additional 2 wk)
   Hydrocodone                     5/325 mg                       Oral              1-2 Tablets every 4 h    As needed
   Gabapentin                      300 mg                         Oral              1 Dose every 6 h         As needed
   Zolpidem                        5-10 mg                        Oral              1 Dose every 4 h         As needed

PONV, postoperative nausea and vomiting.
